$EXPE

Dzielak Robert J sold $661K of EXPE

Dzielak Robert J (Chief Legal Officer & Sec'y) sold 2,000 shares of Expedia Group, Inc. (EXPE) at $330.50 ($0.66M total) on 2026-08-17.

Original reporting
SEC EDGAR · Dzielak Robert J
Published Aug 18, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 18, 2026, 9:17 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$EXPE
Neutral
medium confidence
Mentioned
$EXPE
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$EXPENeutralLow
01

Why it matters

The newest fact is the specific open-market sale by the CLO and Secretary, including share count, price, and post-transaction holdings. It does not include any guidance, legal/regulatory action, or business development.

02

Market read

Traders may monitor insider activity for sentiment, but this filing alone is unlikely to drive a durable repricing without accompanying fundamental news.

03

What to watch

The article does not state whether the sale was part of broader personal liquidity needs, tax planning, or other non-informational motives, limiting interpretability.

Relevance 5/10Novelty 3/10Timing: filed after-hours on Aug. 18, covering a sale dated Aug. 17

Background

The article is an SEC Form 4 insider transaction disclosure for Expedia Group, Inc.

Company-level read

Ticker impact

$EXPENeutralMedium confidence
Context

Expedia’s Chief Legal Officer sold 2,000 shares in an open-market transaction for about $661,000, filed on Aug. 18.

Expected impact

Low likelihood of sustained price impact; any reaction is likely limited to short-term sentiment.

Evidence & confidence

The filing discloses transaction size, price, and that it was an open-market sale, but provides no new company-specific operational or financial information.

Market effects

Minimal, as this is company-specific insider activity without sector-wide signal.

None indicated.

None indicated.

Counterpoint

Insider sales are often planned for liquidity or diversification; the absence of a 10b5-1 plan does not necessarily imply negative expectations.

Key entities

  • Expedia Group, Inc.

    Subject of the Form 4 insider sale disclosure.

  • Dzielak Robert J

    Chief Legal Officer and Secretary who sold 2,000 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ABNBMed

Airbnb Slides to $150 as Wall Street Fears AI Will Skip the Middleman

Airbnb (ABNB) fell 8% to $150 despite 17% revenue growth, as investors reacted to Meta's AI agent Muse, which could bypass travel intermediaries. Booking Holdings (BKNG) and Expedia (EXPE) also dropped. Airbnb's unique inventory and direct host-guest relationships may mitigate AI impact. The stock's consensus target is $184.35.

$METAMed

Meta’s Muse Drags Down Stocks That Depend on ‘Consumer Inertia’

Shares of banks, insurers, and travel agencies fell as investors worry about Meta's AI agent, Muse, disrupting industries reliant on consumer inertia. Meta's stock rose 11% on Monday. Affected companies include JPMorgan, Morgan Stanley, Allstate, Charles Schwab, Expedia, and Booking Holdings. Goldman Sachs identifies telecoms, insurance, and utilities as sectors at risk.

$EXPEMed

Morgan Stanley Cuts Expedia (EXPE) to Underweight as Rivals Pull Ahead on Users

Morgan Stanley downgraded Expedia (EXPE) to Underweight with a $235 price target, citing flat user growth compared to rivals like Booking.com and Airbnb. The analyst noted Expedia's higher marketing costs and exposure to AI-driven search tools. Despite this, Expedia's B2B segment grew 21% in Q2, and the company raised its full-year revenue and margin outlook. The stock has fallen since the downgrade.

$EXPEMed

Wall Street Warning Sends Expedia Shares Sliding

Expedia (EXPE) shares fell after Morgan Stanley initiated coverage with an Underweight rating, citing stagnant user growth and competition. The firm set a $235 price target, despite recent earnings and a smaller upgrade from TD Cowen. Expedia's growth outlook and cash generation remain strong, but debt and slowing revenue growth pose risks.

$EXPEMedAI 8/10

Expedia Stock Is Up Almost 6% This Week. Here’s What’s Behind the Move

Expedia Group (EXPE) stock rose nearly 6% this week after reporting strong Q2 results, beating earnings and revenue estimates for the fifth consecutive quarter. The company raised full-year guidance, citing broad-based growth, particularly in U.S. consumer demand and B2B segment. However, Morgan Stanley initiated coverage with an Underweight rating and a $235 price target, citing concerns about inventory and direct traffic. Expedia's CEO highlighted the company's consistent performance, and a va